KBC Group NV lowered its position in UnitedHealth Group Inc (NYSE:UNH) by 28.5% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 231,661 shares of the healthcare conglomerate’s stock after selling 92,138 shares during the period. KBC Group NV’s holdings in UnitedHealth Group were worth $51,072,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Exane Derivatives increased its stake in shares of UnitedHealth Group by 15,333.3% in the 4th quarter. Exane Derivatives now owns 463 shares of the healthcare conglomerate’s stock worth $102,000 after acquiring an additional 460 shares during the last quarter. Acrospire Investment Management LLC increased its stake in shares of UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares during the last quarter. Intellectus Partners LLC increased its stake in shares of UnitedHealth Group by 18.2% in the 2nd quarter. Intellectus Partners LLC now owns 818 shares of the healthcare conglomerate’s stock worth $152,000 after acquiring an additional 126 shares during the last quarter. Wealthcare Advisory Partners LLC increased its position in shares of UnitedHealth Group by 461.9% during the 3rd quarter. Wealthcare Advisory Partners LLC now owns 826 shares of the healthcare conglomerate’s stock worth $162,000 after purchasing an additional 679 shares during the last quarter. Finally, Legacy Advisors LLC increased its position in shares of UnitedHealth Group by 546.0% during the 4th quarter. Legacy Advisors LLC now owns 801 shares of the healthcare conglomerate’s stock worth $176,000 after purchasing an additional 677 shares during the last quarter. Institutional investors own 86.78% of the company’s stock.
UNH stock opened at $212.55 on Friday. The firm has a market capitalization of $215,614.66, a PE ratio of 19.85, a price-to-earnings-growth ratio of 1.30 and a beta of 0.74. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.73. UnitedHealth Group Inc has a 52-week low of $162.74 and a 52-week high of $250.79.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. During the same quarter last year, the business posted $2.11 EPS. equities research analysts anticipate that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were paid a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s payout ratio is presently 28.01%.
UNH has been the subject of a number of recent analyst reports. Cantor Fitzgerald reissued a “buy” rating and set a $225.00 price objective on shares of UnitedHealth Group in a research report on Monday, November 27th. Jefferies Group reissued a “buy” rating and set a $248.00 price objective on shares of UnitedHealth Group in a research report on Friday, December 1st. Deutsche Bank raised their price objective on UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Royal Bank of Canada raised their price objective on UnitedHealth Group to $244.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 29th. They noted that the move was a valuation call. Finally, Oppenheimer raised their price objective on UnitedHealth Group from $215.00 to $225.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 29th. Two investment analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and an average target price of $244.62.
In other news, Director Kenneth Irwin Shine sold 198 shares of UnitedHealth Group stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the transaction, the director now owns 1,790,567 shares in the company, valued at approximately $434,302,025.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Steven H. Nelson sold 14,233 shares of UnitedHealth Group stock in a transaction dated Thursday, March 15th. The shares were sold at an average price of $230.22, for a total value of $3,276,721.26. Following the completion of the transaction, the chief executive officer now owns 18,219 shares of the company’s stock, valued at approximately $4,194,378.18. The disclosure for this sale can be found here. Insiders sold a total of 77,015 shares of company stock valued at $17,879,199 in the last quarter. Company insiders own 0.89% of the company’s stock.
TRADEMARK VIOLATION WARNING: This report was originally published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this report on another website, it was illegally stolen and republished in violation of US and international trademark & copyright laws. The original version of this report can be accessed at https://ledgergazette.com/2018/03/24/kbc-group-nv-decreases-holdings-in-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.